Home/Filings/4/0001209191-23-012789
4//SEC Filing

Olefson Jonathan 4

Accession 0001209191-23-012789

CIK 0001610950other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 5:08 PM ET

Size

10.4 KB

Accession

0001209191-23-012789

Insider Transaction Report

Form 4
Period: 2023-02-23
Olefson Jonathan
General Counsel & Corp Secty
Transactions
  • Award

    Class A Common Stock

    2023-02-23+60266,206 total
  • Tax Payment

    Class A Common Stock

    2023-02-23$38.25/sh2,001$76,53864,205 total
  • Award

    Class A Common Stock

    2023-02-23+2,60964,713 total
  • Award

    Class A Common Stock

    2023-02-23+89165,604 total
Footnotes (3)
  • [F1]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022.
  • [F2]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full on the date on which the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.
  • [F3]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2024, subject to continued employment.

Issuer

Syneos Health, Inc.

CIK 0001610950

Entity typeother

Related Parties

1
  • filerCIK 0001673025

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:08 PM ET
Size
10.4 KB